CClinicalTrials.gg
CompletedNCT01998945Updated Aug 16, 2016

Back on My Feet: Emotional Recovery From Fall Injury

A Phase 1/2 interventional study of Exposure-based Cognitive Behavioral Therapy and Relaxation Training in Posttraumatic Stress Disorder, Subsyndromal Posttraumatic Stress Disorder and Fear of Falling, sponsored by Weill Medical College of Cornell University. Completed at 1 site in United States. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2016-08-16.

Sponsored by Weill Medical College of Cornell University · Phase 1/2, Interventional, and Treatment

Phase
Phase 1/2
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

We will compare two programs that are designed to help older adults who have had fall injuries manage anxiety and improve their level of functioning. We expect that both programs will provide some benefit, but that one will promote better management.

Read the detailed description

Fall accidents can be frightening experiences that cause life-changing injuries. Each year, millions of older Americans who fall may develop disabling anxiety and related distress, functional limitations, and poor health.

Our previous study adapted a well-researched anxiety treatment, Exposure-based Cognitive Behavioral Therapy (ET), for older adults diagnosed with full posttraumatic stress disorder (PTSD), subsyndromal PTSD, or fear of falling after fall injury. The approach was well-accepted by subjects and they reported both reductions in anxiety and having more fully returned to normal living immediately after the treatment and then three months later.

The purpose of this pilot study is to compare ET to another active treatment, Relaxation Training (RT). Both study treatments will consist of eight home-based sessions. ET consists of education about anxiety, relaxation training, managing distressing thoughts, healthy routine, and confronting avoided memories and situations. RT consists of techniques to ease bodily tension.

Twenty-four subjects will be randomly assigned to one of the two treatment groups. The study will compare how subjects in each group improve on outcomes such as diagnosis, anxiety severity, and quality of life over the course of treatment, and at three- and six-month follow-up.

The findings will provide the basis for larger future studies.

02

Conditions studied

  • Posttraumatic Stress Disorder
  • Subsyndromal Posttraumatic Stress Disorder
  • Fear of Falling

Keywords

  • Exposure therapy
  • Cognitive behavioral therapy
  • Relaxation Training
  • Older Adults
  • Fall Injury
  • Anxiety
  • Posttraumatic Stress
03

In context

Stress Disorders, Traumatic

1,147 studies on the registry are indexed under Stress Disorders, Traumatic; 108 are open to participants now.

This study's enrollment of 22 is below the median of 60 across 908 interventional studies indexed under Stress Disorders, Traumatic.

Browse Stress Disorders, Traumatic studies →

Lead sponsor

Weill Medical College of Cornell University is the lead sponsor of 867 studies on the registry; 160 are open to participants now.

Of its 119 completed or terminated interventional studies of FDA-regulated products, 91 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 60 years and older
  • Fall accident requiring emergency room or inpatient hospital medical care with return home within past nine months
  • Community dwelling
  • Able to ambulate independently or with an assistive device
  • English-speaking
  • Diagnosis of PTSD, subsyndromal PTSD, or Fear of Falling (determined by interview)

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment
  • Serious or terminal illness
  • Aphasia
  • Current substance abuse
  • Lifetime history of psychotic disorder and/or bipolar disorder
  • Active suicidal or homicidal ideation
  • Prescription psychotropic medication begun \< 6 weeks
05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    Exposure-based Cognitive Behavioral Therapy (ET)

    Participants will receive exposure-based cognitive behavioral therapy

    Behavioral: Exposure-based Cognitive Behavioral Therapy

  • Active comparator
    Relaxation Training (RT)

    Participants will receive relaxation training

    Behavioral: Relaxation Training

Interventions

  • BehavioralExposure-based Cognitive Behavioral Therapy

    Eight 75-minute, in-home sessions delivered twice weekly for 4 weeks of exposure-based cognitive behavioral therapy, a time-limited treatment that focuses on confronting avoided memories and situations and identifying and managing distressing thoughts.

  • BehavioralRelaxation Training

    Eight 75-minute, in-home sessions delivered twice weekly for 4 weeks of Relaxation Training, that focus on muscle relaxation and diaphragmatic breathing to address the physical symptoms of anxiety.

06

What researchers measure

Primary outcomes

  1. Change from baseline clinician-rated PTSD at 6 weeks

    Time frame: Baseline, Week 6

Secondary outcomes

  1. Change from baseline fear of falling at 6 weeks

    Time frame: Baseline, Week 6

  2. Change from baseline depression at 6 weeks

    Time frame: Baseline, Week 6

  3. Change from baseline anxiety at 6 weeks

    Time frame: Baseline, Week 6

  4. Change from baseline self-reported PTSD at 6 weeks

    Time frame: Baseline, Week 6

07

Study locations

1 site
  • Weill Cornell Medical College
    New York, New York 10065, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 16, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01998945
Lead sponsor
Weill Medical College of Cornell University
Collaborators
National Institute of Mental Health (NIMH)
Responsible party
Nimali Jayasinghe (Assistant Professor of Psychology, Weill Medical College of Cornell University) — Principal investigator
First posted
Dec 3, 2013
Start date
Dec 2013
Primary completion
Mar 2015
Completion
Sep 2015
Last update
Aug 16, 2016

Study contacts

Nimali Jayasinghe, PhD
principal investigator · Weill Medical College of Cornell University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion